Paclitaxel is a most widely used anticancer drug with low oral bioavailability, thus it is
currently administered via intravenous infusion. DHP107 is a lipid-based paclitaxel …

Paclitaxel (PTX) is one of the most potent intravenous chemotherapeutic agents to date, yet
an oral formulation has been problematic because of its low solubility and permeability …

Therapeutic importance of natural products have been widely explored since ancient time
for benefit of human health although the clinical uses of these natural products still a …

A solid self-emulsifying drug delivery system (SEDDS) of paclitaxel (PTX) was developed
that could enhance its oral bioavailability and neutralize other niggles associated with …

Hydroxy-cleroda-3, 13-dien-16, 15-olide (HCD) which is extracted from a medicinal plant,
Polyalthia longifolia, was shown to exhibit anticancer activity through apoptosis and FAK …

The development of new therapeutic modalities involves the use of drug carrier, such as
liposomes, which can modify pharmacokinetic and bio-distribution of drug profile. Polyene …

Several PEGylated polyester-based nanoncologicals have been proposed in the literature,
some of them nowadays being under preclinical/clinical trials or marketed. In this review, we …

Purpose: The purpose of this study was to develop an optimised formulation for a
nanostructured lipid carrier (NLC) loaded with doxorubicin. Methods: A doxorubicin-loaded …

GJJVAFUKOBZPCB-ZGRPYONQSA-N (R)-3, 4-Dihydro-2-methyl-2-(4, 8, 12-trimethyl-3, 7,
11-tridecatrienyl)-2H-1-benzopyran-6-ol Chemical compound OC1= CC= C2OC (CC/C= C …

Objective: The objective of this study is to prepare nanogels were prepared via ionic
complexation with negatively charged gellan gum. Method: Nanogel of curcumin was …